Clinical Trials Browser

Phase 3 × trilaciclib × Thoracic × Clear all

NCT07473128 2026-03-16

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Phase 3 Not yet recruiting

Limited Stage Small Cell Lung Cancer

NCT04902885 2024-07-10

Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients

Phase 3 Completed

95 enrolled 27 charts

Small Cell Lung Carcinoma